{
    "clinical_study": {
        "@rank": "129463", 
        "arm_group": [
            {
                "arm_group_label": "Simvastatin", 
                "arm_group_type": "Experimental", 
                "description": "simvastatin 20 mg/d is randomized to treat COPD patients for 4 weeks"
            }, 
            {
                "arm_group_label": "B1-6-12", 
                "arm_group_type": "Placebo Comparator", 
                "description": "B1-6-12 one tablet a day is randomized to give to COPD patients for 4 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Airway inflammation is partly driven by Th17 and Th17-polarizing cytokines that is\n      steroid-resistant. Statins could suppress IL-17 cytokines in other diseases such as\n      atherosclerosis and multiple sclerosis in mouse model. The investigators hypothesize that\n      statins might provide anti-inflammatory benefit of suppressing IL-17 cytokines in COPD\n      patients."
        }, 
        "brief_title": "The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "COPD", 
        "condition_browse": {
            "mesh_term": "Pulmonary Disease, Chronic Obstructive"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stable COPD without an exacerbation within 3 months prior to study entry\n\n          -  mild, moderate and severe COPD with or without treatments, regardless of COPD\n             medications\n\n        Exclusion Criteria:\n\n          -  Concomitant other chronic lung diseases including with TB and malignancy\n\n          -  HIV\n\n          -  Being on immunosuppressive drugs and systemic corticosteroids\n\n          -  Dyslipidemic patients with recent cardiovascular or cerebrovascular disease within 6\n             month prior to study entry\n\n          -  Cognitive impairment\n\n          -  Currently on macrolides, azole anti-fungal agents, amiodarone and amlodipine"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01944176", 
            "org_study_id": "Si323/2013"
        }, 
        "intervention": {
            "arm_group_label": "Simvastatin", 
            "intervention_name": "simvastatin, placebo", 
            "intervention_type": "Drug", 
            "other_name": [
                "Bestatin", 
                "B1-6-12"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Simvastatin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "Statins", 
            "Cytokines"
        ], 
        "lastchanged_date": "October 10, 2013", 
        "location": {
            "contact": {
                "email": "sikmn@mahidol.ac.th", 
                "last_name": "Kittipong Maneechotesuwan, MD., PhD", 
                "phone": "024197757"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok-noi", 
                    "country": "Thailand", 
                    "state": "BKK", 
                    "zip": "10700"
                }, 
                "name": "Faculty of Medicine Siriraj Hospital, Mahidol University"
            }, 
            "investigator": {
                "last_name": "Kittipong Maneechotesuwan, MD., PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokines in COPD Patients", 
        "overall_contact": {
            "email": "kittipong.man@mahidol.ac.th", 
            "last_name": "Kittipong Maneechotesuwan, MD., PhD.", 
            "phone": "024197757"
        }, 
        "overall_official": {
            "affiliation": "Faculty of Medicine Siriraj Hospital", 
            "last_name": "Kittipong Maneechotesuwan, MD., PhD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Sputum neutrophils", 
                "safety_issue": "No", 
                "time_frame": "4 weeks after treatment"
            }, 
            {
                "measure": "Sputum cytokines", 
                "safety_issue": "No", 
                "time_frame": "4 weeks after treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01944176"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mahidol University", 
            "investigator_full_name": "Kittipong Maneechotesuwan", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "FEV1", 
            "safety_issue": "No", 
            "time_frame": "4 weeks after treatment"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}